Log in

Webinar 4 - News & Views in anxiety disorders

November 5, 2020 (16:00, UTC+2)

Global Times
7:00 (Los Angeles), 10:00 (New York), 15:00 (London), 16:00 (Paris), 23:00 (Tokyo)

Speakers
Katharina Domschke (Germany)
Presentation Title:
Epidemiology, Taxonomy and Etiology of Anxiety

David Baldwin (United Kingdom)
Presentation Title:
Pharmacotherapy in anxiety disorders

Moderator
Siegfried Kasper (Austria)

Registration Fees per Webinar

  • CINP Member - $20
  • CINP Non-Member - $40
  • Student, Trainee, Fellow - $0 (Proof of student or post doc status is required at time of registration.)

Join the conversation online on Facebook, LinkedIn, or Twitter using our official hashtag: #CINPOnline

Katharina Domschke, Germany (Speaker)

Prof. Katharina Domschke, MA, MD, PhD, is Full Professor and Chair of the Dept. of Psychiatry and Psychotherapy, University of Freiburg, Germany, since 2016. Before that, she was Full Professor and Vice Chair of the Dept. of Psychiatry, University of Wuerzburg, Germany. Her clinical and teaching focus is on the treatment and prevention of anxiety, stress-related, affective and obsessive-compulsive disorders. Scientifically, Prof. Domschke is a renowned expert in genetics, epigenetics, imaging genetics and pharmacogenetics in the targeted treatment and prevention of anxiety, stress-related, affective and obsessive-compulsive disorders as reflected by to date over 290 publications in international journals and an h-index of 46. She has received funding from the EU, the German Research Foundation (DFG) and the German Ministry of Research and Education (BMBF) and is a full member of ACNP, ECNP, ISPG, SOBP and the German National Academy of Sciences Leopoldina. Prof. Domschke serves on the editorial boards of >10 international journals. Her work has been recognized by e.g. the WFSBP Research Award, the WPA Fellowship Award and the ECNP Fellowship Award.

David Baldwin, United Kingdom (Speaker)

David Baldwin is Professor of Psychiatry and Head of the Mental Health Group in the Clinical and Experimental Sciences Academic Unit of the Faculty of Medicine at the University of Southampton in the UK. He trained in medicine at Charing Cross Hospital Medical School, in psychiatry at St Mary's Hospital Medical School and the Maudsley Hospital, and in medical humanities at Birkbeck College. He is an Honorary Professor in the University of Cape Town in South Africa, and Visiting Professor at Shandong Mental Health Centre in Jinan, China.

David is President-Elect of the British Association for Psychopharmacology, Past President of Depression Alliance, a Medical Patron of Anxiety UK, Editor-in-Chief of Human Psychopharmacology, and author of over 300 full articles in peer-reviewed scientific journals.

He aims to improve clinical outcomes in mood and anxiety disorders: by investigating the role of neurobiological and psychological factors in causing and maintaining illness; through improving trial design when evaluating efficacy and tolerability of treatment interventions; by assessing the effectiveness and acceptability of treatment interventions in wider clinical practice; through identifying more accurately those patient groups at particular risk of poor outcomes. Through Southern Health NHS Foundation Trust, he offers a tertiary referral specialist service to patients with treatment-resistant conditions.

Siegfried Kasper, Austria (Moderator)

Dr. Siegfried Kasper is Professor Emeritus of Psychiatry and former Chairman of the Department of Psychiatry and Psychotherapy at the Medical University of Vienna, Austria. Born in Salzburg, Austria, he was educated at the medical schools of the University of Innsbruck, Austria and the Universities of Freiburg and Heidelberg, Germany. Dr. Kasper gained clinical and research experience in psychiatry at the Central Institute of Mental Health, Mannheim, Germany, the Psychiatric Department of the University of Heidelberg, Germany, the Clinical Psychobiology Branch of the National Institute of Mental Health, Bethesda, Maryland/USA, and the Psychiatric Department of the University of Bonn, Germany; in neurology at the Neurological Department of the University of Heidelberg in Mannheim; and psychotherapeutic and psychoanalytic training at the Ausbildungsinstitut für Psychotherapie und Psychoanalyse in Heidelberg/Mannheim, Germany.

Dr. Kasper published more than 600 in PubMed listed publications (Google: Citation Index: 47.641; Hirsch-Index: 104, i10-index: 652) and more than 250 books or book chapters, in various areas of psychiatry. He concentrates on the biological bases of mental disorders and their possible treatment approaches. Furthermore, he has conducted studies in psychopathological as well as clinical areas. Dr Kasper is a frequent national and international speaker and continues to be actively involved in research programmes studying depression, anxiety, psychosis, and dementia.  

Dr. Kasper serves/served on the executive committees and advisory boards of several national and international societies, such as the Austrian Association of Psychiatry, Psychotherapy and Psychosomatic (ÖGPP), the European College of Neuropsychopharmacology (ECNP) and the European Psychiatric Association (EPA). From 2005 to 2009 Dr. Kasper was President of the World Federation of Societies of Biological Psychiatry (WFSBP) and has been appointed as Honorary President of the WFSBP in 2013. He has been elected to the Executive Committee of the International College of Neuropsychopharmacology (CINP) for the period of 2012 to 2018 and is now President of this society. Moreover, Dr. Kasper is Chair of the World Psychiatric Association (WPA) Section of Pharmacopsychiatry. He is Founding President of the Austrian Society of Neuropsychopharmacology and Biological Psychiatry (ÖGPB) and of the Austrian Society of Drug Safety in Psychiatry (ÖAMSP). Furthermore, he is a Honorary Member of the Czech Society of Neuropsychopharmacology, the Romanian Society of Neuropsychopharmacology, the Hungarian Psychiatric Association and a Fellow of the Royal College of Psychiatrists, UK, as well as of the Scandinavian College of Neuro-Psychopharmacology (SCNP) and of the Ukrainian Association of Psychiatry. He is a member of the European Academy of Sciences and Arts (EASA). Furthermore, he has been appointed as Honorary/Visiting Professor at the following universities: University of Hong Kong, China, in 2004; Universidad Andrés Bello, Santiago de Chile, Chile, 2014; Aino University in Osaka, Japan, 2015; Kolkata Institute of Psychiatry, Department of Health & Family Welfare, India in 2016; University of Hiroshima, Japan, in 2017 and Belgrade University School of Medicine, Serbia, in 2017.
Dr. Kasper serves on the editorial boards of numerous learned journals, including The Lancet Psychiatry, CNS Spectrums, Journal of Affective Disorders, Pharmacopsychiatry, European Archives of Psychiatry and Neuroscience. He is Chief-Editor of the International Journal of Psychiatry in Clinical Practice and was Chief-Editor of the World Journal of Biological Psychiatry. He is Field Editor of the International Journal of Neuropsychopharmacology as well as Section Editor of the Annals of General Psychiatry.

As a result of his research expertise he is the recipient of numerous national and international scientific and public awards and prizes and has been acknowledged with the Grand Decoration of Honor in Silver for Services to the Republic of Austria, the Austrian Cross of Honor for Science and Art, First Class, the Gold Medal for Meritorious Service to the Province of Vienna and received in 2019 the City of Vienna Award for Medical Science.

©2019 CINP